Original StudyPharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study
Under a Creative Commons license
open access
Keywords
Creatinine clearance
End-stage renal disease
Glomerular filtration rate
Monoclonal antibody
SLAMF7
Cited by (0)
Copyright © 2016 The Authors. Published by Elsevier Inc.